Skip to content
value.today

Stereotaxis, Inc.

Stereotaxis, Inc. is listed today as Stereotaxis, Inc.: market value, financials and filings are on its company page.

Funding rounds

0 counted as startup funding, 4 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Stereotaxis, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2024$3 MPrivate placement after listing$2 to $10 million

Stereotaxis, Inc.: Private sale, Jul 2024

Investors in this round

1 investor had bought by the notice of Aug 15, 2024: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Stereotaxis, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David L. Fischel · Executive Officer, Director
  • Kimberly R. Peery · Executive Officer, Director
  • Arun S. Menawat · Director
  • David W. Benfer · Director
  • Myriam W. Curet · Director
  • Nachum S. Shamir · Director
  • Nathan W. Fischel · Director
  • Ross B. Levin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Issuance of additional shares is contingent upon achievement of certain product revenue and regulatory approval milestones, currently estimated to be $9,309,800.”

Signed by Kimberly R. Peery, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 15, 2024. Read the notice at the SEC.

equitySEC
Aug 2019$25 MPrivate placement after listing$10 to $50 million

Stereotaxis, Inc.: Private sale, Aug 2019

Investors in this round

6 investors had bought by the notice of Aug 21, 2019: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Stereotaxis, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$25 M of $25 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Convertible preferred stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David L. Fischel · Executive Officer, Director
  • Kevin M. Barry · Executive Officer
  • Martin C. Stammer · Executive Officer
  • Arun S. Menawat · Director
  • David W. Benfer · Director
  • Joe W. Kiani · Director
  • Nathan W. Fischel · Director
  • Robert J. Messey · Director
  • Ross W. Levin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Cowen and Company LLC (CRD 7616) · broker-dealer Cowen and Company LLC (CRD 7616) · New York, New YorkSold in CA, CT, MA, NY

Signed by Martin Stammer, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 21, 2019. Read the notice at the SEC.

equitySEC
Sep 2016$24 MPrivate placement after listing$10 to $50 million

Stereotaxis, Inc.: Private sale, Sep 2016

Investors in this round

12 investors had bought by the notice of Oct 5, 2016: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Stereotaxis, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$24 M of $24 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David A Giffin · Executive Officer · Vice President, Human Resources.
  • Frank J. Cheng · Executive Officer · Senior Vice President, Marketing and Business Development.
  • Karen Witte Duros · Executive Officer · Sr. Vice President, General Counsel and Secretary.
  • Martin C Stammer · Executive Officer · Chief Financial Officer.
  • Paul A. Brathwaite · Executive Officer · Vice President, Research and Development.
  • William C. Mills III · Executive Officer, Director · Chairman of the Board and Chief Executive Officer.
  • Arun A Menawat · Director
  • David A Fischel · Director
  • David W. Benfer · Director
  • Duane N DeSisto · Director
  • Eric N Prystowsky · Director
  • Fred A. Middleton · Director
  • Joseph A Kiani · Director
  • Robert J. Messey · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Karen Witte Duros, Sr. Vice President, General Counsel & Secretary. Source: SEC Form D, newest notice filed Oct 5, 2016. Read the notice at the SEC.

equity, optionsSEC
May 2012$8 MPrivate placement after listing$2 to $10 million

Stereotaxis, Inc.: Private sale, May 2012

Investors in this round

9 investors had bought by the notice of May 25, 2012: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Stereotaxis, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$25 million to $100 million
Sales commissions
none
Finders' fees
$1,302,802
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David A. Giffen · Executive Officer
  • Frank J. Cheng · Executive Officer
  • Karen W. Duros · Executive Officer
  • Michael P. Kaminski · Executive Officer, Director
  • Samuel W. Duggan · Executive Officer
  • Christopher D. Alafi · Director
  • David W. Benfer · Director
  • Eric N. Prystowsky · Director
  • Fred A. Middleton · Director
  • Joseph D. Keegan · Director
  • Robert J. Messey · Director
  • William C. Mills · Director
  • William M. Kelley · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • OPPENHEIMER & CO. INC. (CRD 249) · New York, New YorkSold in CA, NY, OK

Signed by Karen Witte Duros, Senior Vice President, General Counsel. Source: SEC Form D and 1 amendment, newest notice filed May 25, 2012. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Stereotaxis, Inc., its revenue in fiscal 2025 came from these product and service lines: Disposables Service and Accessories $22.15 million (68%), Systems $10.22 million (32%).

    Annual report (SEC XBRL) · Dec 2025

  • Stereotaxis, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2024).

    SEC Form D · Aug 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2024

Products and services#

No products or services of Stereotaxis, Inc. are on record.

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in Stereotaxis, Inc.
InvestorKindAmountRoundRoleSource
DAFNA Capital Management LLCFund or asset managernot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2018)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.

Largest shareholders today

Institutions holding Stereotaxis, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Stereotaxis, Inc.
NameRoleNamed in
David L. FischelExecutive officerAug 2024
Kimberly R. PeeryExecutive officerAug 2024
Kevin M. BarryExecutive officerAug 2019
Martin C. StammerExecutive officerAug 2019
David A GiffinVice President, Human Resources.Oct 2016
Frank J. ChengSenior Vice President, Marketing and Business Development.Oct 2016
Karen Witte DurosSr. Vice President, General Counsel and Secretary.Oct 2016
Martin C StammerChief Financial Officer.Oct 2016
Paul A. BrathwaiteVice President, Research and Development.Oct 2016
William C. Mills IIIChairman of the Board and Chief Executive Officer.Oct 2016
David A. GiffenExecutive officerMay 2012
Karen W. DurosExecutive officerMay 2012
Michael P. KaminskiExecutive officerMay 2012
Samuel W. DugganExecutive officerMay 2012
Arun S. MenawatDirectorAug 2024
David L. FischelDirectorAug 2024
David W. BenferDirectorAug 2024
Kimberly R. PeeryDirectorAug 2024
Myriam W. CuretDirectorAug 2024
Nachum S. ShamirDirectorAug 2024
Nathan W. FischelDirectorAug 2024
Ross B. LevinDirectorAug 2024
Joe W. KianiDirectorAug 2019
Robert J. MesseyDirectorAug 2019
Ross W. LevinDirectorAug 2019
Arun A MenawatDirectorOct 2016
David A FischelDirectorOct 2016
Duane N DeSistoDirectorOct 2016
Eric N PrystowskyDirectorOct 2016
Fred A. MiddletonDirectorOct 2016
Joseph A KianiDirectorOct 2016
William C. Mills IIIChairman of the Board and Chief Executive Officer.Oct 2016
Christopher D. AlafiDirectorMay 2012
Eric N. PrystowskyDirectorMay 2012
Joseph D. KeeganDirectorMay 2012
Michael P. KaminskiDirectorMay 2012
William C. MillsDirectorMay 2012
William M. KelleyDirectorMay 2012

Went public since 2011. Its SEC number is that of a company listed on a stock exchange.